| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/19/2000 | EP0586520B1 Backbone modified oligonucleotide analogs |
| 04/19/2000 | EP0567528B1 Depot formulations |
| 04/19/2000 | CN1251133A Bi or multifunctional molecules based on dendroaspin scaffold |
| 04/19/2000 | CN1251112A Cross-linked vinyl polymers with bile acid adsorbing effect |
| 04/19/2000 | CN1251105A 2,3-dihydrofuro [3,2-b] pyridin, prepn. and application thereof of therapy |
| 04/19/2000 | CN1251100A Method for making arylamino triazolopyridines |
| 04/19/2000 | CN1251099A Thiazole benzenesulfonamides as beta 3 agoniste for treatment of diabetes and obesity |
| 04/19/2000 | CN1251097A Phthalazines with angiogenesis inhibiting activity |
| 04/19/2000 | CN1251095A Lipase capalyzed dynamic resolution of isoxazoline thioester to isoxazoline carboxylic acids |
| 04/19/2000 | CN1251093A Process for producing optically active imidazole compound, intermediates for synthesizing same |
| 04/19/2000 | CN1251091A New compound |
| 04/19/2000 | CN1251043A Use of protein extractable from animal organs for prepn. of medicaments for treatment of pathological conditions |
| 04/19/2000 | CN1251038A IL-8 receptor antagonists |
| 04/19/2000 | CN1251021A 宠物食品组合物 Pet food composition |
| 04/19/2000 | CN1250776A Heterodicyclic compound derivatives |
| 04/19/2000 | CN1250771A Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
| 04/19/2000 | CN1250669A Ion composite type water-soluble pharmaceutical compositions, and use thereof |
| 04/19/2000 | CN1250660A Liquid medicine for treating wound and pain |
| 04/19/2000 | CN1250652A Compositions contg. benzoxazinone and nucleoside like materials |
| 04/19/2000 | CN1051548C Heterobicyclic derivatives, pharmaceutical compositions contg. same, mfg. method and use thereof |
| 04/19/2000 | CN1051545C 5-(aryloxymethyl) oxazolines, process for prepn. thereof and pharmaceutical compositions contg. same |
| 04/18/2000 | US6051713 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 04/18/2000 | US6051711 Acid hydrolysis in the presence of a c1-c4 alkanol to obtain a crystalline salt of swainsonine |
| 04/18/2000 | US6051686 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 04/18/2000 | US6051613 Nitrogen monoxide production suppressor |
| 04/18/2000 | US6051610 Compounds useful as neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics |
| 04/18/2000 | US6051587 Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
| 04/18/2000 | US6051584 Viricides; fungicides; bactericides |
| 04/18/2000 | US6051583 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indoles, processes for preparing them and their use as pharmaceutical compositions |
| 04/18/2000 | US6051581 Spiro-azabicyclic compounds useful in therapy |
| 04/18/2000 | US6051580 Neurokinin antagonist; antiasthma agent |
| 04/18/2000 | US6051577 N-7-heterocyclyl pyrrolo[2,3-D]pyrimidines and the use thereof |
| 04/18/2000 | US6051565 Farnesyl-protein transferase inhibitors |
| 04/18/2000 | US6051563 Methods for the administration of amifostine and related compounds |
| 04/18/2000 | US6051234 Health diet for preventing diseases caused by life-habit |
| 04/18/2000 | US6051228 Antibodies against human CD40 |
| 04/18/2000 | US6051227 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 04/18/2000 | US6051217 Administering to patient with hematopoietic or immunodeficiency |
| 04/15/2000 | CA2284853A1 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
| 04/13/2000 | WO2000020636A1 Methods of identifying inverse agonists of the serotonin 2a receptor |
| 04/13/2000 | WO2000020635A1 ANTISENSE MODULATION OF INTEGRIN α4 EXPRESSION |
| 04/13/2000 | WO2000020607A2 Chimaeric proteins between members of tgf-beta superfamily |
| 04/13/2000 | WO2000020598A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | WO2000020591A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 04/13/2000 | WO2000020590A2 G-protein coupled receptor proteins |
| 04/13/2000 | WO2000020576A2 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein |
| 04/13/2000 | WO2000020570A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020446A2 Bax-mediated apoptosis modulating reagents and methods |
| 04/13/2000 | WO2000020443A1 Novel peptides |
| 04/13/2000 | WO2000020440A1 Caspases and apoptosis |
| 04/13/2000 | WO2000020432A1 Antisense modulation of bcl-x expression |
| 04/13/2000 | WO2000020429A1 3',5'-cyclic phosphate compounds and methods thereof |
| 04/13/2000 | WO2000020423A1 Tricyclic δ3-piperidines as pharmaceuticals |
| 04/13/2000 | WO2000020422A1 BENZOTHIENO[3,2-c]PYRIDINES AS α2 ANTAGONISTS |
| 04/13/2000 | WO2000020421A2 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS |
| 04/13/2000 | WO2000020401A1 New bis-benzimidazoles |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020394A1 Benzamide derivatives as thrombin inhibitors |
| 04/13/2000 | WO2000020391A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 04/13/2000 | WO2000020390A1 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 04/13/2000 | WO2000020378A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 04/13/2000 | WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | WO2000020371A1 Prostaglandin receptor ligands |
| 04/13/2000 | WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | WO2000020041A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | WO2000020026A2 Compositions and methods for inhibiting angiogenesis |
| 04/13/2000 | WO2000020025A2 Akt compositions for enhancing survival of cells |
| 04/13/2000 | WO2000020024A2 Methods for the treatment of non-thyroid disorders |
| 04/13/2000 | WO2000020020A2 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 04/13/2000 | WO2000020013A1 Reduction of oxidative stress factors |
| 04/13/2000 | WO2000020012A1 Agent called 'astromelanin'/'astronella' for treating pathological conditions |
| 04/13/2000 | WO2000020003A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000020001A1 Mglur5 antagonists for the treatment of pain and anxiety |
| 04/13/2000 | WO2000019998A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | WO2000019989A2 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | WO2000019824A1 Novel treatment for stroke management |
| 04/13/2000 | WO2000003015A3 Human transport protein homologs |
| 04/13/2000 | WO2000002877A3 New pharmaceutically active compounds |
| 04/13/2000 | WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 04/13/2000 | WO2000002545A3 Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain |
| 04/13/2000 | WO2000000608A3 Immune system molecules |
| 04/13/2000 | WO2000000603A3 Modularly constructed rna molecules having two sequence region types |
| 04/13/2000 | WO2000000509A3 Peptides for inhibiting hpv e7 proteins |
| 04/13/2000 | WO1999065490A3 Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
| 04/13/2000 | WO1999065462A3 Use of aminosterol derivatives as chloride ionphores |
| 04/13/2000 | WO1999059563A3 Cabergoline and pramipexole for treating cns diseases, especially parkinson's disease |
| 04/13/2000 | WO1999029687A8 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
| 04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
| 04/13/2000 | CA2346665A1 Novel treatment for stroke management |
| 04/13/2000 | CA2346537A1 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 04/13/2000 | CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | CA2346443A1 Prostaglandin receptor ligands |
| 04/13/2000 | CA2346363A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | CA2346333A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | CA2346070A1 Bax-mediated apoptosis modulating reagents and methods |
| 04/13/2000 | CA2346040A1 New bis-benzimidazoles |
| 04/13/2000 | CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | CA2346034A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |